Canvax Biotech

canvaxbio.com

For 16 years, Canvax has been an original manufacturer and supplier of the most innovative solutions, services, kits and R&D Reagents inside the Molecular Biology field. Thanks to our reliable, cost-effective and easy-to-use products, we enable our worldwide customers to improve its laboratory productivity and accelerate their discoveries.Based in Córdoba (Spain), since its foundation Canvax has focused on R&D of multiplex high throughput platforms (HTS) for Drug discovery and Diagnostic applied biosensors. Over a decade later, Canvax is a worldwide leading expert in Molecular Biology and GPCR expression in heterologous cells, with important patents and exclusive know-how.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Diagnostics

AVANTOR® TO COLLABORATE WITH GEMINIBIO TO BRING CUSTOM HYDRATED SOLUTIONS AND CELL CULTURE MEDIA TO BIOPHARMA CUSTOMERS

Avantor | June 24, 2022

news image

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry. Custom hydrated solutions and cell culture media are critical components of the bioproduction workflow, especially for emerging modalities such as gene therapy. This c...

Read More

Industrial Impact

AKILI ANNOUNCES PUBLIC COMPANY BOARD OF DIRECTOR NOMINEES

Akili Interactive | July 11, 2022

news image

Akili Interactive a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, announced the nominees for its future board of directors, effective upon the closing of Akili’s business combination with Social Capital Suvretta Holdings Corp. I subject to customary closing conditions. Shares of the new public company’s common stock are expected to trade on Nasdaq under the symbol “AKLI.” Akili’...

Read More

CYTOGENETICS MARKET IS NEW BUSINESS OPPORTUNITIES AND INVESTMENT RESEARCH REPORT BY 2026

Publicist360 | April 09, 2020

news image

Cytogenetics is a branch of biology, which correlates cytology and genetics. The correlation is used to study chromosomes and genes in cells and tissues. The study is conducted in relation to hereditary and variations in genes and number of chromosomes, which are used for the detection of genetic disorders as well as selection of precise therapies for treatment of these genetic disorders. Cytogenetics includes various techniques such as comparative genomic hybridization, fluorescence in situ hyb...

Read More

Cell and Gene Therapy

SPATIAL BIOLOGY CRO FLAGSHIP BIOSCIENCES ACQUIRES PHARMA SERVICES BUSINESS FROM INTERPACE BIOSCIENCES

Flagship Biosciences, Inc. | September 01, 2022

news image

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions. This acquisition follows a growth equity investment in Flagship from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies. The strategic combination of Flagship and IPS creates a full repert...

Read More
news image

Diagnostics

AVANTOR® TO COLLABORATE WITH GEMINIBIO TO BRING CUSTOM HYDRATED SOLUTIONS AND CELL CULTURE MEDIA TO BIOPHARMA CUSTOMERS

Avantor | June 24, 2022

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry. Custom hydrated solutions and cell culture media are critical components of the bioproduction workflow, especially for emerging modalities such as gene therapy. This c...

Read More
news image

Industrial Impact

AKILI ANNOUNCES PUBLIC COMPANY BOARD OF DIRECTOR NOMINEES

Akili Interactive | July 11, 2022

Akili Interactive a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, announced the nominees for its future board of directors, effective upon the closing of Akili’s business combination with Social Capital Suvretta Holdings Corp. I subject to customary closing conditions. Shares of the new public company’s common stock are expected to trade on Nasdaq under the symbol “AKLI.” Akili’...

Read More
news image

CYTOGENETICS MARKET IS NEW BUSINESS OPPORTUNITIES AND INVESTMENT RESEARCH REPORT BY 2026

Publicist360 | April 09, 2020

Cytogenetics is a branch of biology, which correlates cytology and genetics. The correlation is used to study chromosomes and genes in cells and tissues. The study is conducted in relation to hereditary and variations in genes and number of chromosomes, which are used for the detection of genetic disorders as well as selection of precise therapies for treatment of these genetic disorders. Cytogenetics includes various techniques such as comparative genomic hybridization, fluorescence in situ hyb...

Read More
news image

Cell and Gene Therapy

SPATIAL BIOLOGY CRO FLAGSHIP BIOSCIENCES ACQUIRES PHARMA SERVICES BUSINESS FROM INTERPACE BIOSCIENCES

Flagship Biosciences, Inc. | September 01, 2022

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions. This acquisition follows a growth equity investment in Flagship from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies. The strategic combination of Flagship and IPS creates a full repert...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us